Buy this article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this article you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.



March 2004, Volume 34 Number 3 , p 30 - 30




  • Source

    Administering beta-blockers to patients with diabetes and heart failure improves survival rates, say Australian researchers who analyzed data from six trials of beta-blocker therapy in patients with heart failure. About 25% of the 13,000 patients in the trials had diabetes. They found that patients with diabetes who received a beta-blocker for heart failure were 16% less likely to die than those with diabetes who didn't receive a beta-blocker.

    Overall, diabetes increases the risk of death from heart failure by about 25%. But despite the proven value of beta-blockers in treating heart failure, many clinicians are reluctant to prescribe these drugs to patients with diabetes out of concern for the effect on glucose levels. This research could convince clinicians that the benefits of beta-blockers for diabetic patients with heart failure outweigh the risks.


    “Are Beta-Blockers as Efficacious in Patients ...

To continue reading, buy this article for just $3.95.

Have a coupon or promotional code? Enter it here: